LOC100420587: A Drug Target / Disease Biomarker (G100420587)
LOC100420587: A Drug Target / Disease Biomarker
LOC100420587 is a protein that is expressed in various tissues of the body, including the brain, heart, kidneys, and liver. It is a member of the T-cell antigen 6 (TCA6) family, which is a group of hematopoietic stem cell (HSC) antigens that are expressed in a variety of tissues throughout the body.
LOC100420587 is of particular interest as a potential drug target because it is involved in the regulation of immune cell function and has been implicated in a number of diseases, including cancer, autoimmune disorders, and neurodegenerative diseases.
One of the most significant functions of LOC100420587 is its role in the regulation of T-cell development and function. T-cells are a type of immune cell that play a critical role in protecting the body against infection and disease. LOC100420587 is involved in the development and proliferation of T-cells, as well as in the regulation of their subsetting and maturation.
In addition to its role in T-cell development, LOC100420587 is also involved in the regulation of inflammation. T-cells are a key source of cytokines, which are pro-inflammatory molecules that play a critical role in the inflammatory response. LOC100420587 is involved in the regulation of the production and function of cytokines, as well as in the regulation of their effects on other immune cells.
The identification of LOC100420587 as a potential drug target is based on a number of different approaches. One of the most significant findings that has been observed in studies of LOC100420587 is its involvement in the regulation of autoimmune diseases, such as rheumatoid arthritis and multiple sclerosis. These diseases are characterized by the production of antibodies that mistake the self-cells for foreign and cause inflammation. LOC100420587 is involved in the regulation of the production and function of antibodies, which are a key component of the immune response.
Another potential mechanism by which LOC100420587 may be involved in the regulation of immune cell function is its role in the regulation of cancer cell growth and survival. LOC100420587 has been shown to be expressed in a variety of cancer types, including breast, lung, and ovarian cancer. Additionally, studies have suggested that LOC100420587 may be involved in the regulation of cancer cell stem cell properties, which could potentially make it an attractive target for anti-cancer drugs.
In addition to its potential role in the regulation of immune cell function, LOC100420587 is also of interest as a potential biomarker for a variety of diseases. The expression of LOC100420587 has been shown to be associated with a number of diseases, including cancer, autoimmune disorders, and neurodegenerative diseases. Additionally, studies have shown that LOC100420587 may be a potential target for small molecules and other compounds that are currently being used for the treatment of these diseases.
Overall, LOC100420587 is a protein that is of interest as a potential drug target or biomarker due to its involvement in the regulation of immune cell function and its association with a variety of diseases. Further research is needed to fully understand the role of LOC100420587 in these processes and to explore its potential as a drug or biomarker.
Protein Name: SHC Binding And Spindle Associated 1 Pseudogene
The "LOC100420587 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC100420587 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
LOC100421561 | LOC100505498 | LOC100505502 | LOC100505585 | LOC100505664 | LOC100505715 | LOC100505716 | LOC100505841 | LOC100505912 | LOC100505915 | LOC100505978 | LOC100506023 | LOC100506071 | LOC100506076 | LOC100506124 | LOC100506207 | LOC100506236 | LOC100506274 | LOC100506281 | LOC100506379 | LOC100506403 | LOC100506422 | LOC100506444 | LOC100506446 | LOC100506472 | LOC100506474 | LOC100506499 | LOC100506514 | LOC100506532 | LOC100506606 | LOC100506634 | LOC100506639 | LOC100506667 | LOC100506730 | LOC100506974 | LOC100507002 | LOC100507006 | LOC100507053 | LOC100507054 | LOC100507156 | LOC100507165 | LOC100507221 | LOC100507250 | LOC100507336 | LOC100507346 | LOC100507351 | LOC100507389 | LOC100507412 | LOC100507424 | LOC100507443 | LOC100507513 | LOC100507520 | LOC100507547 | LOC100507577 | LOC100507656 | LOC100509646 | LOC100533709 | LOC100630923 | LOC100652743 | LOC100652768 | LOC100652833 | LOC100652999 | LOC100653061 | LOC100996385 | LOC100996412 | LOC100996583 | LOC100996637 | LOC100996643 | LOC100996664 | LOC100996770 | LOC101060017 | LOC101060106 | LOC101060179 | LOC101060400 | LOC101060445 | LOC101060524 | LOC101060632 | LOC101448202 | LOC101593348 | LOC101926887 | LOC101926948 | LOC101926953 | LOC101926959 | LOC101926969 | LOC101927002 | LOC101927020 | LOC101927025 | LOC101927026 | LOC101927040 | LOC101927053 | LOC101927060 | LOC101927066 | LOC101927082 | LOC101927108 | LOC101927143 | LOC101927164 | LOC101927166 | LOC101927169 | LOC101927179 | LOC101927188
